ArticleJournal of neurochemistry2021
A new brain-penetrant glucosylceramide synthase inhibitor as potential Therapeutics for Gaucher disease.
Takahiro Fujii et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
11 papers cite it
this papercites it